×
About 425 results

ALLMedicine™ Anaplastic Oligodendroglioma Center

Research & Reviews  133 results

Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma
https://clinicaltrials.gov/ct2/show/NCT00588523

Oct 4th, 2022 - The purpose of this study is to see how effective treatment of high doses of chemotherapy is for your tumor. We will also be looking at the side effects and risks of this treatment. You will receive very high doses of chemotherapy. High doses of c...

The Multiple Rib Osteomyocutaneous Split Latissimus Dorsi Flap for Calvarial Reconstruc...
https://doi.org/10.1097/SCS.0000000000008754
The Journal of Craniofacial Surgery; Klein HJ, Giovanoli P et. al.

Jul 30th, 2022 - Major complex cranial defects may be challenging for the reconstructive microsurgeon. Affected patients often present with impaired soft tissues including dura exposure or fistulas. The lacking structural bony support may cause severe neurological...

The correlation analysis of TERT promoter mutations with IDH1/2 mutations and 1p/19q de...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302255
Medicine Xu J, Xu FP et. al.

Jul 23rd, 2022 - To investigate the correlations between mutations in the telomerase reverse transcriptase (TERT) promoter and isocitrate dehydrogenase (IDH) 1 and 2 mutations or 1p/19q deletion in human gliomas. TERT promoter gene and IDH gene mutations in 110 gl...

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
https://clinicaltrials.gov/ct2/show/NCT03434262

Apr 4th, 2022 - Patients will be stratified by the molecular and histologic characteristics of their tumor to one of three treatment strata. STRATUM A: Combination Treatment: ribociclib and gemcitabine. Patient Population: Participants with a diagnosis of refract...

5-Aminolevulinic acid-enhanced fluorescence-guided treatment of high-grade glioma using...
https://doi.org/10.3171/2022.1.JNS212562
Journal of Neurosurgery; Strickland BA, Wedemeyer M et. al.

Mar 19th, 2022 - 5-Aminolevulinic acid (5-ALA)-enhanced fluorescence-guided resection of high-grade glioma (HGG) using microscopic blue light visualization offers the ability to improve extent of resection (EOR); however, few descriptions of HGG resection performe...

see more →

Guidelines  1 results

Central nervous system cancers.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124889
Journal of the National Comprehensive Cancer Network : JN... Nabors LB, Ammirati M et. al.

Sep 14th, 2013 - Primary and metastatic tumors of the central nervous system are a heterogeneous group of neoplasms with varied outcomes and management strategies. Recently, improved survival observed in 2 randomized clinical trials established combined chemothera...

see more →

Clinicaltrials.gov  23 results

Intensive Chemotherapy and Autotransplantation for Patients With Newly Diagnosed Anaplastic Oligodendroglioma
https://clinicaltrials.gov/ct2/show/NCT00588523

Oct 4th, 2022 - The purpose of this study is to see how effective treatment of high doses of chemotherapy is for your tumor. We will also be looking at the side effects and risks of this treatment. You will receive very high doses of chemotherapy. High doses of c...

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
https://clinicaltrials.gov/ct2/show/NCT03434262

Apr 4th, 2022 - Patients will be stratified by the molecular and histologic characteristics of their tumor to one of three treatment strata. STRATUM A: Combination Treatment: ribociclib and gemcitabine. Patient Population: Participants with a diagnosis of refract...

Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors
https://clinicaltrials.gov/ct2/show/NCT00303849

Mar 17th, 2022 - PRIMARY OBJECTIVES: I. To evaluate toxicity and estimate the maximum tolerated dose (MTD) of melphalan (intra-arterially [i.a.]) administered in conjunction with carboplatin (i.a.) and etoposide phosphate (intravenously [i.v.]) undergoing BBBD, in...

Topotecan in Treating Patients With Recurrent Brain Tumors
https://clinicaltrials.gov/ct2/show/NCT00003372

Apr 8th, 2020 - OBJECTIVES: I. Determine the efficacy of topotecan in patients with recurrent anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma. II. Determine the qualitative and quantitative toxicity of topotecan in this patient population on thi...

Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma
https://clinicaltrials.gov/ct2/show/NCT00400816

Sep 18th, 2018 - OBJECTIVES: Determine progression-free survival of patients with newly diagnosed anaplastic oligodendroglioma (AO) or mixed oligoastrocytoma (MOA) treated with temozolomide. Determine the response rate in these patients. Assess the quality of life...

see more →

News  10 results

Diagnostic and Prognostic Markers in Glioblastoma
https://www.onclive.com/view/diagnostic-and-prognostic-markers-in-glioblastoma

Apr 2nd, 2021 - Transcript:Susan C. Pannullo, MD: The patient who has a glioblastoma will often present with neurologic symptoms, as one would expect. These can include headache, progressive neurologic deficit, and seizures. With the progressive neurologic defici...

Classification and Prognosis of Glioblastoma
https://www.onclive.com/view/classification-and-prognosis-of-glioblastoma

Apr 2nd, 2021 - Transcript:Daniela Bota, MD: The diagnosis of glioblastoma has changed a lot during the last years. Originally, the diagnosis was made after the tumor was resected by taking pieces of the tissue and looking at it under the microscope. And the 2 ch...

5 Abstracts Offer Snapshot of Immunology Research
https://www.onclive.com/view/5-abstracts-offer-snapshot-of-immunology-research

Dec 5th, 2020 - The carcinoembryonic antigen (CEA) vaccinia has been researched for more than 20 years. Investigational Glioma Vaccine Results Promising A novel vaccine based on dendritic cells and peptides proved to be safe and capable of delivering an im...

Chemoradiation Established as New Standard in Glioma Subtypes
https://www.onclive.com/view/chemoradiation-established-as-new-standard-in-glioma-subtypes

Dec 5th, 2020 - Martin J. Van Den Bent, MD A study that unfolded over 17 years has established combination chemotherapy after radiotherapy (RT) as a new standard of care for patients with anaplastic oligodendroglial tumors that contain 1p/19q chromosomal co-del...

Plenary Sunday at ASCO
https://www.onclive.com/view/plenary-sunday-at-asco

Dec 5th, 2020 - Andrew L. Pecora, MD Editor-in-Chief Oncology & Biotech News Chief Innovations Officer, Professor, and Vice President of Cancer Services John Theurer Cancer Center at Hackensack University Medical Center I am sure any of ...

see more →

Patient Education  3 results see all →